🇮🇳

Index Intelligence

· daily

BSE Metal Sector Regulatory Filings — October 29, 2026

Across the 11 filings for the India BSE METAL stream dated 2026-10-29, the dominant theme is an active Q2 FY27 earnings season among metal constituents, with several companies (Vedanta, JSW Steel, Hindalco/Novelis, Lloyds Metals, APL Apollo) disclosing call logistics or transcripts that carry the substantive numbers outside the filings themselves. The only filings with hard quantitative content are APL Apollo Tubes (record Q2 volume of 960,000 tons and EBITDA per ton of Rs. 6000, with FY27 EBITDA guidance above Rs. 2200 crore) and Lloyds Metals (USD 130 million SOFR+450 secured notes plus a Crisil AA/Stable reaffirmation and two fresh NCD assignments totalling Rs. 6,450 crore of rated NCDs). Period-over-period comparisons are largely absent in the enriched data for this batch, so trend synthesis is limited; the clearest directional read is APL Apollo's record quarter offset by export and Dubai disruption. Lloyds Metals is the most active issuer in the batch, with a debt-funded growth profile (new secured USD notes, rating reaffirmation, and a board meeting on 03 November 2026 to consider a fundraise), which concentrates both the catalyst flow and the leverage question. Adani Enterprises' two Monitoring Agency reports show no deviation from stated use of proceeds (Rs. 24,930.30 crore rights issue and Rs. 15,000 crore QIP), which is a clean governance signal. Promoter activity at Jindal Steel (Jindal Power's routine 0.034% purchase) is immaterial. Overall the batch leans neutral with a positive credit signal and one mixed operating update.

2 high priority 9 medium 11 total filings
· daily

BSE Auto Sector Regulatory Filings — October 29, 2026

Across the 11 filings for the S&P BSE AUTO stream dated 2026-10-29, the majority are administrative or procedural (analyst meet schedules, audio recordings, UPSI code updates, a product launch), with only two carrying hard financial data. The clearest quantitative signal comes from Schaeffler India, whose Q3 CY26 presentation shows top-line strength (standalone revenue up 27.4% YoY to Rs 30,058 mn and 12.1% QoQ; 9M revenue up 21.4% YoY) undermined by weaker earnings quality: EBITDA margin fell to 18.7% from 20.2% YoY and free cash flow dropped 81.7% YoY to Rs 408 mn on higher working capital and Rs 1,822 mn of capex. Maruti Suzuki's EV export milestone (cumulative shipments above 50,000 units, roughly 93% of India's electric passenger vehicle exports in April-September 2026 and over 50% of passenger vehicle exports) is the most positive operating development, anchored by the 1 million-unit Hansalpur capacity. Bajaj Auto disclosed three upcoming investor events (16 November, 17 November, 2 December), which signals active investor engagement but no new numbers. Bharat Forge's Q2/H1 FY27 results call on 5 November 2026 is the nearest hard catalyst in the set. Samvardhana Motherson's EUR 75 mn guarantee for a wholly owned subsidiary is immaterial to consolidated numbers but notable as a financing-structure disclosure. No insider trading, dividend, buyback, or M&A valuation data was present in the enriched fields for these filings, so conviction signals rely on operating disclosures rather than insider behaviour.

11 medium 11 total filings
· daily

BSE FMCG Sector Regulatory Filings — October 29, 2026

Ten filings were reviewed for the India BSE FMCG stream on 2026-10-29. Nine are new filings and one is context. Eight filings concern Godrej Consumer Products (GCPL), Tata Consumer Products, United Spirits and Radico Khaitan; two (United Spirits and Radico Khaitan) are admin or meeting notices with no financials. The dominant theme is a widening gap between strong consolidated top-line growth and softer standalone profitability: GCPL consolidated revenue rose 19.0% YoY to ₹4,413.09 Cr and consolidated PAT rose 13.9% to ₹522.92 Cr, yet standalone PAT fell 5.3% YoY to ₹337.33 Cr and standalone operating margin contracted to 21.4% from 22.5%. Input-cost inflation (LPG, tea, salt) and a ~150 bps trade inventory correction are compressing margins across the sector. Tata Consumer's India tea/coffee revenue fell 1% with flat volumes, while its growth businesses rose 40%. GCPL's Q2 consolidated profit was partly supported by exceptional items, and its Latin America & Others EBITDA margin fell to 0.9%. The interim dividend of ₹5/share (record date November 4, 2026, payment by November 27, 2026) and reiterated FY27 guidance are the main near-term catalysts. No insider transactions, pledges, or M&A were disclosed in these filings.

4 high priority 6 medium 10 total filings
· daily

BSE Pharma Sector Regulatory Filings — October 29, 2026

Three filings dated 29 October 2026 (with one earlier-context Torrent filing) form a thin, mostly administrative digest for the S&P BSE PHARMA constituent set. The most material development is Mankind Pharma's CRISIL action: the AA+/Stable rating was reaffirmed on ₹2,500 crore of NCDs (₹400 crore and ₹2,100 crore tranches), while the ₹2,500 crore NCD rating and ₹1,500 crore A1+ commercial paper rating were withdrawn, with no reason disclosed in the filing itself. Biocon's No. 13 ranking among Science's Top 20 Global Employers is a reputational positive with no financial content. Torrent's Regulation 30(6) intimation points to a Q2/H1 FY2026-27 earnings call transcript, but the substantive numbers are not in the provided material, so no period-over-period comparisons can be extracted. No insider trading, dividend, buyback, M&A, or guidance data appears in any filing, which limits quantitative synthesis. The key analytical gap is that the withdrawal rationale must be obtained from CRISIL's rationale document before drawing conclusions about Mankind's credit profile.

1 high priority 2 medium 3 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — October 29, 2026

All five filings relate to a single S&P BSE REALTY constituent, Brigade Enterprises Limited, so this digest is a deep read on one company rather than a sector sweep. The quarter ended 30 September 2026 shows a clear divergence: top-line revenue contracted (consolidated revenue from operations down 13.5% YoY to Rs 1,19,636 lakh; H1 FY27 revenue down about 12%), while profitability expanded sharply (consolidated profit for the quarter up 28.5% to Rs 21,882 lakh; standalone PAT more than doubled to Rs 11,449 lakh). The profit improvement is driven largely by a 38.5% YoY fall in land purchase costs (to Rs 52,518 lakh from Rs 85,441 lakh) and a shift in revenue mix, rather than by volume growth. Sales momentum is mixed: Q2 FY27 pre-sales of Rs 1,827 Cr were up 72% QoQ but down 10% YoY, with H1 pre-sales down 8% YoY, and residential was the bright spot while commercial pre-sales fell 49% YoY. Annuity and hospitality segments are a stabilising feature, with leasing at 90% occupancy and hospitality RevPAR up 10% YoY to Rs 5,922. Governance and capital activity is routine: an unmodified auditor review and a new Rs 525 ESOP grant at a 2.48% discount to the prior close. The key market question is whether margin gains are sustainable as the top line keeps shrinking.

3 high priority 2 medium 5 total filings
· daily

BSE IT Technology Sector Regulatory Filings — October 29, 2026

Five filings from S&P BSE IT constituents were reviewed for 29 October 2026, but the enriched data fields (period-over-period comparisons, forward-looking guidance, insider activity, capital allocation, and transaction valuations) are essentially empty across all of them. The filings themselves are largely administrative or product-oriented: Hexaware's board-approved results lack headline revenue or profit figures in the body of the filing, Wipro completed a 20% stake acquisition in FLARRE.AI ahead of schedule, Zensar published its Q2FY27 earnings call recording, Coforge launched an AI-native Autonomous Software Factory operating model, and Infosys Finacle announced banking innovation awards. Because no period-over-period revenue, margin, or guidance figures are supplied, no quantitative trend analysis across the portfolio is possible, and this digest does not infer financial performance that the filings do not disclose. The most material item is Hexaware's governance overhaul, including a CEO transition from R Srikrishna to Vivek Jetley, board resignations, and entity rationalization via slump sale and mergers, which warrants attention pending the annexures. Sentiment is mixed-to-neutral overall, with positive tones attached to Coforge and Infosys product and recognition news. Investors should obtain Hexaware's enclosed results annexures and Zensar's recorded call before drawing any valuation conclusions.

5 medium 5 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — October 29, 2026

Across the 23 filings for the SENSEX 30 stream (period 29 Oct 2026), the dominant theme is top-line growth coexisting with sharp margin pressure from input-cost inflation and currency weakness. Asian Paints posted Q2 FY27 consolidated revenue of ₹9,953.89 Cr (+16.9% YoY) and standalone PAT of ₹1,095.55 Cr (+14.6% YoY), yet consolidated PBDIT margin fell 202 bps to 15.6% and standalone profit fell 25.9% QoQ as cost of materials rose about 35% YoY. InterGlobe Aviation (IndiGo) illustrates the same squeeze in a more extreme form: revenue rose 25.9% YoY to INR 233,638 Mn, but fuel CASK rose 68.9%, the rupee depreciated about 9.2% (USD/INR average 95.09 vs 87.06), and the net loss before forex widened to INR 7,237 Mn from a profit of INR 1,039 Mn. Trent delivered solid YoY growth (standalone revenue +22.5%, net profit +8.6%), but its Debt Service Coverage Ratio fell to 1.38 from 2.85 and inventories rose about 24% versus March 2026, a watch-worthy working-capital signal. Governance news was concentrated at Trent, where Chairman Noel N. Tata retires effective 11 November 2026 and Bahram Vakil takes over from 12 November. Remaining filings (NTPC BESS commissioning, Maruti EV export milestone, SBI investor meet, Reliance and Infosys routine notices) were operational or low-materiality. Net read: headline growth is intact, but earnings quality and margin resilience across consumer and aviation names deserve closer scrutiny than top-line prints suggest.

9 high priority 14 medium 23 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — October 28, 2026

Both filings concern BSE BANKEX constituents: Punjab National Bank (PNB) reported Q2 FY27 standalone net profit of Rs 553,223 lakh, up 12.8% YoY, with half-year profit up 63.9%, and gross NPA improved to 2.55% from 3.45%, though quarter-on-quarter profit growth slowed to 5.3%. AU Small Finance Bank reported Q2 FY27 PAT of INR858 Cr (up 53% YoY), deposits up 29% YoY and loans up 25% YoY, but flagged sequential margin compression of 9 bps to 5.8% and a rising-rate environment that could cap cost-of-funds gains. Both banks show strong year-on-year earnings momentum, but both reports carry mixed signals: PNB's headline profit is flattered by a one-off Rs 4,143.55 crore Investment Fluctuation Reserve transfer and falling other income (-17.1% YoY), while AU SFB faces sequential margin pressure and regulatory fee-income headwinds. The common theme is that asset-quality improvement and credit growth are supporting earnings, while treasury income weakness and rate-cycle risk are the main offsets. Neither filing contains insider transaction, dividend, buyback, or explicit forward-guidance data, so conviction signals are limited to reported operating metrics.

2 medium 2 total filings
· daily

BSE Metal Sector Regulatory Filings — October 28, 2026

The BSE METAL stream for 28 October 2026 is dominated by Q2 FY27 results from Vedanta and Adani Enterprises, both reported with mixed sentiment because headline growth coexists with sharply weaker bottom lines. Vedanta posted record consolidated revenue of Rs 25,812-26,356 crore (up 57% YoY), EBITDA up 106% YoY and PAT of Rs 6,202 crore (up 151% YoY), with net debt falling Rs 4,624 crore QoQ to Rs 3,675 crore (Net Debt/EBITDA 0.1x), yet Copper International sales fell 74% YoY and standalone posted a loss of Rs 170 crore, with comparability distorted by the 1 May 2026 demerger. Adani Enterprises reported H1 consolidated revenue of Rs 71,569 crore (up 62% YoY) and record H1 EBITDA of Rs 11,958 crore (up 56% YoY), but consolidated PAT fell sharply (Q2 down 64% to Rs 1,221 crore on the filing's basis; H1 turned negative) after the Rs 2,644 crore OFAC settlement, and AEL's credit rating was upgraded to AA/Stable. Capital-structure signals are constructive across the group, including Vedanta's interim dividend of Rs 5 per share and Adani's Rs 15,000 crore QIP and Rs 24,907 crore rights issue with largely on-track utilisation. Administrative and governance filings from SAIL, NALCO, Lloyds Metals and Vedanta's ESOS grant add little quantitative content but flag new government nominee directors at SAIL and a USD 130 million secured note at Lloyds.

4 high priority 15 medium 19 total filings
· daily

BSE Auto Sector Regulatory Filings — October 28, 2026

Across the 21 BSE AUTO filings dated 28 October 2026, the dominant theme is a sharp divergence between top-line momentum and profitability. Hero MotoCorp (standalone revenue +21% YoY, PAT +5%, EBITDA margin flat at 13.4%), Hyundai Motor India (revenue +18.3% YoY, standalone PAT -24.3%, consolidated EBITDA margin down to 9.5% from 13.9%) and TVS Motor (revenue +44% YoY, but leverage rising sharply at standalone net debt/equity 0.37x vs 0.25x) all show volume-led growth being absorbed by commodity and operating cost inflation. TVS Motor delivered the strongest headline print (record 1.9 million units, PAT +52%), yet its EBITDA margin expanded only 30 bps and sequential NBFC profit fell. Corporate-structure activity dominates the governance stream: TVS Motor's composite scheme (demerger of the consumer finance business, roughly 11% of turnover) and the Rs. 530 Cr STPL acquisition, plus Hero's Rs. 300 Cr investment in its Netherlands holding, signal active portfolio restructuring. Market implication: headline growth is being rewarded less than margin durability, and investors should differentiate between volume beneficiaries and cost-exposed names while tracking the EPR/ELV regulatory overhang that Hero has flagged as unquantified.

11 high priority 10 medium 21 total filings
· daily

BSE FMCG Sector Regulatory Filings — October 28, 2026

Across the 14 filings for the BSE FMCG stream dated 28 October 2026, the dominant story is a sharp divergence between top-line momentum and margin/profit quality. Hindustan Unilever (HUL) delivered its strongest Underlying Sales Growth in 14 quarters (USG 15%, UVG 7%, Turnover Rs 18,071 Cr), yet EBITDA margin contracted 140 bps YoY to 22.6% and reported PAT was flat at Rs 2,796 Cr because the prior-year base carried a Rs 273 Cr one-off tax gain; PAT before exceptional items grew 9%. United Spirits (USL) showed similar mixed prints: Q2 FY27 standalone NSV grew 2.8% and H1 NSV 4.2%, but Q2 EBITDA fell 4.3% with margin down 146 bps to 19.7%, while the Popular segment's NSV dropped 22.7% on Maharashtra MML and Karnataka excise changes. Consolidated USL profit was pressured by a Rs 32 Cr loss from the Sports (RCSPL) business reclassified as discontinued operations, pending BCCI approval of the sale, which is expected within 12 months. Portfolio-level pattern: top-line growth is being bought through price/mix and A&P rather than volume, with cost pressure from West Asia and rising advertising intensity compressing margins. Emami's filing is administrative only, and the remaining HUL and USL governance and personnel filings are routine, so the market-moving content is concentrated in HUL's Q2 print, the USL segment disclosures, and the pending RCSPL sale.

5 high priority 9 medium 14 total filings
· daily

BSE Pharma Sector Regulatory Filings — October 28, 2026

Three BSE PHARMA constituent filings were published on 2026-10-28: GlaxoSmithKline Pharmaceuticals' analyst/investor meet notice (4 Nov 2026), Dr. Reddy's USFDA 'Voluntary Action Indicated' classification for its Srikakulam FTO-SEZ Process Unit-02, and IPCA Laboratories' Q2FY27 earnings call notice (5 Nov 2026). The filings contain no quantitative period-over-period comparisons, insider trading data, capital allocation changes, transaction valuations, or forward guidance, so enriched financial fields are largely empty and the digest rests on regulatory and event-driven signals. The dominant theme is regulatory and disclosure-cycle activity: Dr. Reddy's faces a non-penal but still-actionable US quality finding at a facility that matters for export supply, while two peers are scheduling investor engagement that will bring the first hard numbers (IPCA's Q2FY27 results) within a week. The market-relevant takeaway is that near-term sentiment in the sector will hinge on the IPCA results and any management commentary on the Dr. Reddy's remediation timeline, rather than on anything disclosed today.

3 medium 3 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — October 28, 2026

Six filings from the S&P BSE REALTY constituent set were reviewed, with four newly published and two included for context. Four of the six filings concern Anant Raj Limited, so the digest is weighted heavily toward that single name, and its results show consistent top-line and profit growth alongside a warning sign in balance sheet mechanics. Consolidated revenue from operations rose 4.9% YoY to ₹661.53 Cr and PAT rose 13.3% YoY to ₹156.49 Cr, while H1 FY27 revenue grew 5.7% and EBITDA reached ₹418.11 Cr. Margin quality is mixed: depreciation more than doubled to ₹26.50 Cr from ₹10.64 Cr, employee costs rose to ₹10.89 Cr from ₹8.97 Cr, and consolidated cash fell to ₹718.33 Cr from ₹899.46 Cr since March 31, 2026, while consolidated inventories surged to ₹1,507.37 Cr from ₹1,057.59 Cr. The most material corporate event is The Phoenix Mills' NCLT-approved buyout of CPP Investments' 41.67% stake in ISMDPL for ₹1,350 Cr cash, which lifts its holding to 68.10%, though completion is still gated by the awaited certified order. Prestige Estates' board meeting on November 5, 2026 and closed trading window through November 7 are routine scheduled events. Market implication: earnings momentum is intact, but the working-capital build and cash drawdown in Anant Raj warrant verification in the upcoming disclosures before extrapolating profit growth.

3 high priority 3 medium 6 total filings
· daily

BSE IT Technology Sector Regulatory Filings — October 28, 2026

Across the 15 filings for the S&P BSE IT constituent stream (dated 2026-10-28), the dominant theme is a split between top-line stability and margin or cash pressure. KPIT Technologies is the most data-rich name: Q2 FY27 revenue rose 6.5% YoY to ₹16,909.66M and 0.9% QoQ, but consolidated profit fell 28.6% YoY to ₹1,206.57M as employee costs (+10.1% YoY) and forex losses outran revenue, and net cash dropped from ₹9.0B to ₹6.2B on dividends and working capital. Infosys is the most market-significant development: management cut FY27 constant-currency growth guidance to 1%-2% from 1.5%-3%, even as AI revenue reached 10.5% of revenue and TCV was $5.2bn, pointing to volume softness and pricing pressure rather than demand collapse. Cyient shows the same bifurcation, with DET EBIT margin at a 10-quarter high of 14.2% but organic DET revenue growing only 1.6% QoQ, with growth carried by the acquired TAO Digital. Governance and corporate-action filings (KPIT board approvals, LTM NDR notice, Coforge sponsorship, HCL nano-GCC launch) are largely neutral and low-materiality, with GCC-focused product launches from LTM and HCL being the most notable strategic signals. Portfolio-level, the sector is trading growth for margin defense and capital return, and near-term catalysts hinge on guidance credibility and Q3 margin trajectories.

4 high priority 11 medium 15 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — October 28, 2026

The 18 filings for the S&P BSE SENSEX 30 stream on 2026-10-28 are dominated by two Sensex constituents: Adani Ports and Special Economic Zone (APSEZ) and Hindustan Unilever (HUL), with the rest comprising earnings-calendar notices from Power Grid, NTPC and Bharti Airtel, a Titan subsidiary incorporation, an Infosys guidance cut, and an HCL Technologies product launch. Top-line momentum is strong at APSEZ (consolidated revenue up ~24% YoY to ₹11,340 Cr) and HUL (USG 15%, highest in 14 quarters, UVG 7%), but earnings quality is weaker than headlines suggest: APSEZ standalone PAT fell ~40% sequentially and Logistics EBITDA grew only 8% on 21% revenue growth, while HUL's EBITDA margin contracted 140 bps to 22.6% and reported PAT was flat YoY because of a one-off ₹273 Cr tax gain in the base period. Infosys is the clearest negative, cutting FY27 constant-currency revenue growth guidance to 1-2% from 1.5-3% on softer volumes and pricing pressure, even as AI revenue rose to 10.5% of revenue and large-deal TCV reached $5.2 bn. The dominant portfolio pattern is growth driven increasingly by price/mix and high-margin pockets rather than broad volume expansion, with mixed sentiment on most of the material filings. Near-term catalysts cluster around the 1 November 2026 Power Grid board meeting, the 31 October NTPC call, the 6 November Bharti Airtel call, and HUL's ₹19 interim dividend (record date 12 November).

6 high priority 12 medium 18 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — October 27, 2026

Four BSE BANKEX constituent filings were published for 27 October 2026, but none contain quantitative period-over-period financial data, forward guidance, insider trading volumes, dividend or buyback figures, or M&A valuations; the enriched fields are effectively empty for this batch. The substantive items are governance and capital-structure events: HDFC Bank's CEO transition (Mr. Anup Bagchi assumed charge as MD & CEO on 27 October 2026 after Mr. Jagdishan's tenure ended on 26 October), Canara Bank's RBI-approved exercise of a ₹1,500 crore Basel III Additional Tier I call option, and IndusInd Bank's routine ESOP grant of 55,106 options at ₹904.80 with a 3-year graded vesting. IndusInd also filed a transcript notice for its 23 October 2026 earnings call covering Q2 and H1 FY27 results, but the filing carries no figures. Market implications are modest: the leadership handover at HDFC Bank is the highest-materiality item (6/10), while the Canara call option is neutral to mildly positive for capital management as it implies replacement or refinancing of higher-cost AT1 debt. No portfolio-level margin or growth trend can be inferred from these filings, and conclusions should be treated as provisional until quantitative disclosures are available.

4 medium 4 total filings
· daily

BSE Metal Sector Regulatory Filings — October 27, 2026

Two of the three filings are from Steel Authority of India Limited (SAIL), the largest in-scope name in this stream, and both show a strong half-year: H1 FY27 standalone PAT of ₹3,409.73 Cr versus ₹1,112.27 Cr a year earlier, and H1 revenue up about 10.7% YoY. Q2 FY27 revenue of ₹31,997.51 Cr was up 19.8% YoY but slightly below the prior quarter's ₹26,245.64 Cr on a sequential basis, so the growth is largely year-on-year rather than momentum-driven. The bullish earnings picture is tempered by governance problems flagged by auditors (missing independent and woman directors affecting the Audit and Nomination & Remuneration Committees), a ₹2,712.55 Cr government sales emphasis booked at provisional prices, a ₹216.70 Cr exceptional VRS charge, and investigations into officers over pricing decisions. Operationally, crude steel output grew only about 3% in H1 and Q2 EBITDA (₹4,561 Cr) barely moved from Q1 (₹4,356 Cr), while finance cost stayed elevated at ₹1,016 Cr for H1. Lloyds Metals and Energy's filing is a neutral, administrative update on executed Group Captive power agreements with Amplus entities, with no deal values disclosed. Overall, the stream shows earnings recovery at the largest integrated producer, but investors should weigh that against governance and pricing-related overhangs and limited volume growth.

1 high priority 2 medium 3 total filings
· daily

BSE Auto Sector Regulatory Filings — October 27, 2026

Across the 27 BSE AUTO-constituent filings dated 27 October 2026, the dominant theme is strong top-line growth paired with margin compression: Maruti Suzuki reported Q2 FY27 volume up 26.5% and net sales up 26.1%, yet operating EBITDA margin fell 330 bps to 9.4% and PAT fell 26.9%, driven by West Asia-linked commodity costs, adverse FX and mark-to-market losses on surplus investments. Schaeffler India showed a similar pattern (revenue +27.4% YoY, PBT margin down about 100 bps to 16.5%), while Bajaj Auto printed a strong quarter (standalone revenue up roughly 34%, consolidated profit up about 62%) but with sharply higher finance and employee costs on a consolidated basis. Tata Motors' standalone revenue rose 42% YoY, but EBIT margin slipped 50 bps and management attributed a ~590 bps commodity headwind that was largely offset by operating leverage and pricing. The single largest corporate event is Tata Motors/TML CV Holdings' successful tender for Iveco Group, with approximately 89.42% of share capital tendered at EUR 14.40 per share (EUR 3.43 billion aggregate) and payment due 30 October 2026, followed by a reopened acceptance window on 2-6 November. Balkrishna Industries' Pirelli offtake and Tata Motors' 3,000-unit Amazon electric truck deal add growth optionality, while routine governance items (board appointments, trading-window closures, ESOP allotments, a FEMA compounding at Samvardhana Motherson) carry limited market impact.

8 high priority 19 medium 27 total filings
· daily

BSE FMCG Sector Regulatory Filings — October 27, 2026

Across the nine filings for the S&P BSE FMCG stream dated 27 October 2026, the dominant theme is divergence between volume-led top-line strength and softening cash conversion and quarter-on-quarter momentum. Radico Khaitan reported a record Q2 FY27 with revenue from operations up 16.8% YoY to ₹1,745.1 Cr, EBITDA up 51.0% to ₹356.5 Cr and margins expanding to 20.4%, driven by a 35.8% jump in Prestige & Above volumes and 49% growth in vodka, while its Regular segment volumes fell 9.7% and receivables rose 27.5% since March 2026. United Breweries showed a sharper sequential deceleration, with Q2 FY27 standalone revenue down 21.9% QoQ and PAT down 18.3% QoQ, even as year-to-date revenue grew 15.7% and profit rose 31.1%, and it carries an unprovided ₹75,183 Lakh CCI penalty contingency. Radico also disclosed a DRI customs visit (industry-wide, no reported operational impact) and a CFO-to-Executive-Director elevation effective 28 October 2026, which signals governance continuity rather than stress. Britannia and Varun Beverages filings are event notices only (earnings calls on 6 and 30 October 2026) with no financial data. Investor focus should center on Q3 results quality, Radico's net-debt-free target in H2 FY27, and UBL's contingent liabilities and sequential run-rate.

3 high priority 6 medium 9 total filings
· daily

BSE Pharma Sector Regulatory Filings — October 27, 2026

Across the nine filings, the dominant story is a sharp profitability squeeze at Cipla despite top-line resilience: consolidated revenue of INR 7,404 Cr was down 2% YoY but up 4% QoQ, while EBITDA fell about 27% YoY to INR 1,388 Cr, the margin compressed roughly 630-720 bps (25.0% to 18.7%), and PAT dropped 35% to INR 878 Cr, driven by a 12% YoY rise in employee costs and a steep fall in other operating income. Cipla's One India franchise (+12% YoY to a record INR 3,516 Cr) and a sequential North America recovery to $172 Mn offset weakness in North America in INR terms (-19% YoY) and API/Others (-59%), and the reported top line is also flattered or distorted by a reclassification of INR 131 Cr of sales promotion expenses into revenue reduction, which lowers revenue without affecting profit. Mankind Pharma presents the contrasting growth profile: FY26 revenue of INR 14,278 Cr with an 18.1% FY21-26 CAGR, Q2 FY27 volume growth of 6.2% versus IPM 5.2%, and value growth of 15.7% ex-Tirzepatide against IPM 14.2%, alongside a EUR 48 Mn bet on Armed Cell Therapeutics and a targeted shift of chronic revenue from ~39% to ~50% by FY30E. Governance and incentive items (Cipla's board appointment of Ms Rashmi Joshi, ESOS/ESAR grants, and Max Healthcare's shareholder approval of a PRSU scheme and CMD remuneration) are procedural and carry low materiality. The sector read-through is that Indian branded pharma and hospitals retain volume and pricing momentum, while margin defence depends on cost discipline that Cipla has not yet demonstrated.

2 high priority 7 medium 9 total filings